Search Results

There are 5018080 results for: content related to: Relationship between thiazolidinedione use and cardiovascular outcomes and all-cause mortality among patients with diabetes: a time-updated propensity analysis

  1. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications

    Diabetes/Metabolism Research and Reviews

    Volume 25, Issue 2, February 2009, Pages: 112–126, Andrew Krentz

    Version of Record online : 13 FEB 2009, DOI: 10.1002/dmrr.937

  2. Improving cardiovascular risk – applying evidence-based medicine to glucose-lowering therapy with thiazolidinediones in patients with type 2 diabetes

    International Journal of Clinical Practice

    Volume 63, Issue 9, September 2009, Pages: 1354–1368, M. Fisher

    Version of Record online : 10 AUG 2009, DOI: 10.1111/j.1742-1241.2009.02150.x

  3. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study

    Pharmacoepidemiology and Drug Safety

    Volume 19, Issue 4, April 2010, Pages: 343–350, Laurent Azoulay, Verena Schneider-Lindner, Sophie Dell'Aniello, Kristian B. Filion and Samy Suissa

    Version of Record online : 8 DEC 2009, DOI: 10.1002/pds.1883

  4. Clinical and demographic characteristics of patients receiving different oral hypoglycemic agents

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 8, August 2009, Pages: 756–760, Tara Gomes, David N. Juurlink, Lorraine L. Lipscombe and Muhammad M. Mamdani

    Version of Record online : 28 APR 2009, DOI: 10.1002/pds.1750

  5. You have free access to this content
    The backbone of oral glucose-lowering therapy: time for a paradigm shift?

    Fundamental & Clinical Pharmacology

    Volume 23, Issue 6, December 2009, Pages: 651–667, Jochen Seufert

    Version of Record online : 11 MAR 2009, DOI: 10.1111/j.1472-8206.2009.00676.x

  6. You have free access to this content
    Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-γ agonists in cultured hippocampal neurons

    Journal of Neurochemistry

    Volume 109, Issue 6, June 2009, Pages: 1800–1811, Tristano Pancani, Jeremiah T. Phelps, James L. Searcy, Michael W. Kilgore, Kuey-Chu Chen, Nada M. Porter and Olivier Thibault

    Version of Record online : 22 APR 2009, DOI: 10.1111/j.1471-4159.2009.06107.x

  7. You have free access to this content
    Thiazolidinediones: effects on insulin resistance and the cardiovascular system

    British Journal of Pharmacology

    Volume 153, Issue 4, February 2008, Pages: 636–645, C E Quinn, P K Hamilton, C J Lockhart and G E McVeigh

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0707452

  8. Thiazolidinediones as anti-inflammatory and anti-atherogenic agents

    Diabetes/Metabolism Research and Reviews

    Volume 24, Issue 1, January 2008, Pages: 14–26, Antonio Ceriello

    Version of Record online : 7 NOV 2007, DOI: 10.1002/dmrr.790

  9. You have free access to this content
    Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis

    Hepatology

    Volume 50, Issue 4, October 2009, Pages: 1087–1093, Amalia Gastaldelli, Stephen A. Harrison, Renata Belfort-Aguilar, Lou Jean Hardies, Bogdan Balas, Steven Schenker and Kenneth Cusi

    Version of Record online : 9 JUN 2009, DOI: 10.1002/hep.23116

  10. Thiazolidinedione derivatives in diabetes and cardiovascular disease: an update

    Fundamental & Clinical Pharmacology

    Volume 22, Issue 3, June 2008, Pages: 247–264, Pantelis A. Sarafidis

    Version of Record online : 15 APR 2008, DOI: 10.1111/j.1472-8206.2008.00568.x

  11. Cardiovascular effects of the thiazolidinediones

    Diabetes/Metabolism Research and Reviews

    Volume 22, Issue 2, March/April 2006, Pages: 88–97, Rehan Qayyum and Peter Schulman

    Version of Record online : 26 SEP 2005, DOI: 10.1002/dmrr.596

  12. You have free access to this content
    A Meta-Analysis of the Effect of Thiazolidinediones on Blood Pressure

    The Journal of Clinical Hypertension

    Volume 8, Issue 1, January 2006, Pages: 19–28, Rehan Qayyum and Jurga Adomaityte

    Version of Record online : 31 JAN 2007, DOI: 10.1111/j.1524-6175.2005.04784.x

  13. Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 4, April 2008, Pages: 312–328, R. E. Buckingham and A. Hanna

    Version of Record online : 16 JAN 2007, DOI: 10.1111/j.1463-1326.2006.00700.x

  14. You have free access to this content
    Treating type 2 diabetes: how safe are current therapeutic agents?

    International Journal of Clinical Practice

    Volume 63, Issue 2, February 2009, Pages: 321–332, J. Philippe and D. Raccah

    Version of Record online : 15 JAN 2009, DOI: 10.1111/j.1742-1241.2008.01980.x

  15. You have free access to this content
    Diabetes and skeletal health

    Journal of Diabetes

    Volume 1, Issue 4, December 2009, Pages: 246–254, Subhashini YATURU

    Version of Record online : 17 AUG 2009, DOI: 10.1111/j.1753-0407.2009.00049.x

  16. Risk of acute myocardial infarction in patients treated with thiazolidinediones or other antidiabetic medications

    Pharmacoepidemiology and Drug Safety

    Volume 18, Issue 2, February 2009, Pages: 166–174, Karen M. Stockl, Lisa Le, Shaoang Zhang and Ann S.M. Harada

    Version of Record online : 24 DEC 2008, DOI: 10.1002/pds.1700

  17. You have free access to this content
    Thiazolidinedione therapy for nonalcoholic steatohepatitis: Go, stop, or proceed with caution?

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 366–369, Stephen A. Harrison

    Version of Record online : 30 NOV 2009, DOI: 10.1002/hep.23473

  18. The role of pioglitazone in modifying the atherogenic lipoprotein profile

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 8, August 2009, Pages: 742–756, M. Hanefeld

    Version of Record online : 10 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01048.x

  19. Thiazolidinediones, insulin resistance and obesity: finding a balance

    International Journal of Clinical Practice

    Volume 60, Issue 10, October 2006, Pages: 1272–1280, J. WILDING

    Version of Record online : 8 SEP 2006, DOI: 10.1111/j.1742-1241.2006.01128.x

  20. Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones

    Diabetes, Obesity and Metabolism

    Volume 7, Issue 6, November 2005, Pages: 675–691, C. J. Bailey

    Version of Record online : 3 MAY 2005, DOI: 10.1111/j.1463-1326.2005.00497.x